Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the IntellO2 - Precision Flow Automatic FiO2 Controller to Manual Control for Optimizing Oxygenation in Preterm Infants Receiving High Flow Nasal Cannula Therapy

NCT02074774 is registered in ClinicalTrials.gov with Vapotherm, Inc. as lead sponsor.

NCT NCT02074774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02074774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the IntellO2 - Precision Flow Automatic FiO2 Controller to Manual Control for Optimizing Oxygenation in Preterm Infants Receiving High Flow Nasal Cannula Therapy
Lead sponsor
Vapotherm, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
January 31, 2018
Enrollment
36 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

oxygen titration in preterm infants to manage lung disease